BOYDSense, an award-winning startup with R&D in France and the U.S., is a pioneer in the development of non-invasive breath analysis solutions for the risk stratification, screening, monitoring and detection of different biomarkers.

BOYDSense is currently developing its first product, a miniaturized breath analyzer for monitoring glucose concentration in pre-diabetics and type 2 diabetics. The device detects the type and concentration of volatile organic compounds in breath. The solution is pain-free, affordable, and produces significantly less waste compared to existing fingerstick blood glucose or continuous glucose monitors.

Keywords: Healthcare, Medical Devices, Breath Analysis, Chronic Conditions, Diagnostics, Disease screening, Diabetes Monitoring Device, Health Information, Health Monitoring Device.